Clinical Trial Update: Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating brinzolamide for chronic central serous chorioretinopathy. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Brinzolamide (Brinzolamide)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Central Serous Chorioretinopathy | Phase 2 | Status: UNKNOWN